Cingulate has a total of 17 patents globally, out of which 1 have been granted. Of these 17 patents, 58% patents are active. United States Of America is where Cingulate has filed the maximum number of patents, followed by Australia and Japan. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Cingulate.
Cingulate was founded in 2012. Cingulate operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. As of May 2022, Cingulate has a market value of $13.46 Million.
Do read about some of the most popular patents of Cingulate which have been covered by us in this article and also you can find Cingulate patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cingulate patent portfolio.
How many patents does the CEO of Cingulate have?
The CEO, Shane J. Schaffer has 0 patents.
How many patents does Cingulate have?
Cingulate has a total of 17 patents globally. These patents belong to 1 unique patent families. Out of 17 patents, 10 patents are active.
How Many Patents did Cingulate File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Cingulate Applications Filed||Cingulate Patents Granted|
How many Cingulate patents are Alive/Dead?
How Many Patents did Cingulate File in Different Countries?
Countries in which Cingulate Filed Patents
|United States Of America||3|
|Hong Kong (S.A.R.)||1|
What Percentage of Cingulate US Patent Applications were Granted?
Cingulate (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.00%.
Below are the key stats of Cingulate patent prosecution at the USPTO.
EXCLUSIVE INSIGHTS COMING SOON!
What are Cingulate key innovation segments?